Posted in | News | Sustainable Technologies | Composites | Energy | Building and Construction | Automotive Materials

Dow and Cyclics Sign Global Marketing Agreement

Apr 29 2003

Related Stories

Building on the success of the resin development alliance of last April between Dow and Cyclics Corp, a new long term agreement between Dow Automotive and Cyclics has been signed. The new agreement covers the marketing of the cyclic form of polybutylene terephthalate (CBT) resin into the global automotive, bus, truck and rail markets.

Dow will develop markets which build on the unique properties of CBT. Such markets include automotive structural composites, crash energy dissipation, occupant protection with vertical and horizontal body panels such as truck boxes and tailgates being initial target areas.

Claimed advantages of CBT resins over more conventional materials include weight savings, lower scrap rates, lower tooling costs and recyclability.

For more information on automotive composites, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback